HomeNewsBusinessReal EstateCOVID-19 2nd wave: Will it pave the way for supremacy of listed real estate developers?

COVID-19 2nd wave: Will it pave the way for supremacy of listed real estate developers?

The current liquidity crisis in the system has a lot to do with weaker developers going from bad to worse. RERA regulation has added to their financial woes with both the bank and the non-bank funding being skewed in favour of big players.

May 11, 2021 / 12:24 IST
Story continues below Advertisement
Over the last one year, many smaller and weak players have either been wiped out
Over the last one year, many smaller and weak players have either been wiped out

With the second wave of COVID-19 hitting the country hard, small and medium sized developers are struggling for survival but big listed developers, especially the listed ones, seem to be growing in strength. Most larger, organised and branded players are leveraging the advantage of better cash flows, operational efficiency, dependence on IT and marketing prowess.

Over the last one year, many smaller and weak players have either been wiped out while others have come under the shadow of big developers. Will this trend of organised listed players exercising monopoly over smaller players continue going forward?

Story continues below Advertisement

The pandemic has proved to be a blessing in disguise for big listed developers as in the current environment, boys have been separated from men.

Despite the challenging environment, the top listed companies performed very well on the sales front. According to rating agency ICRA, the top 10 listed companies in real estate witnessed 61 percent growth in the December quarter, though the overall market was 24 percent lower than the pre-COVID-19 level. The sales by top 10 listed players rose from 17.28 msf in FY17 to 28.07 msf in 9M FY21.The market share of sales of top 10 listed realty developers has almost doubled from 11 percent of sales in FY20 to 19 percent in FY21.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show